Effectiveness of ustekinumab in Crohn’s disease across intestinal locations: spotlight on isolated small intestinal involvement
Yue Yu, Wen Hu, Shuyan Li, Hanwen Chen, Yan Chen · 2025
Read Effectiveness of ustekinumab in Crohn’s disease across intestinal locations: spotlight on isolated small intestinal involvement by Yue Yu, Wen Hu, Shuyan Li, Hanwen Chen, Yan Chen (2025) in the Tower of Babel, a free online library of public-domain works preserved in clean, searchable text. No sign-up. The full text is served as a plain-text file at a predictable URL, where text is present: https://antarctic-labs.com/tower-of-babel/pmc-12743847.txt.
Description
Yue Yu and four co-authors test a biologic drug, ustekinumab, in Crohn's disease, with a focus on cases limited to the small intestine, in a study published in twenty twenty-five. Crohn's disease inflames the gut, and disease in the small bowel alone often needs stronger drugs and more surgery. Few studies had checked how well this drug works by disease site.
The team followed patients for a year, using scopes, scans, ultrasound, and lab tests to judge healing. They compared patients whose disease sat in the small bowel with those whose disease reached the large bowel. Outcomes included full remission, healing of the gut lining, and healing through the whole bowel wall. The study gives site-by-site evidence for planning care.
Catalog record
| CREATOR | Yue Yu, Wen Hu, Shuyan Li, Hanwen Chen, Yan Chen |
|---|---|
| YEAR | 2025 |
| COLLECTION | PAPERS |
| FORMAT | TXT |
| FILE SIZE | 40 KB |
| VERSION | 1.0 |
| LICENSE | CC BY 4.0 |
| RIGHTS | CC BY |
| SOURCE | Europe PMC |